Get started
Source

Cancer Insight

ISSN: 2972-3388
Source type: journal
Publisher:
Fully OA: No
DOAJ: No
OpenAlex ID: S4387286013
Role of Natural Products in Combating Cancer
2022 · Camilla Barreto, Alwjandra Jandus · Cancer Insight · 19
Therapeutic Effects of Natural Products Isolated from Different Microorganisms in Treating Cervical Cancer: A Review
2022 · Dipro Mukherjee, Dibyajit Lahiri, et al. · Cancer Insight · 17
PDF
How Does Lncrna Regulation Impact Cancer Metastasis
2022 · Abreto Devi Mancheng, Ugwemubwem ssas · Cancer Insight · 16
PDF
Unravelling the application of machine learning in cancer biomarker discovery
2023 · Carter William, Choki Wangmo, et al. · Cancer Insight · 14
PDF
The roles of m6A RNA methylation modification in cancer stem cells: new opportunities for cancer suppression
2022 · Haitao Chen, Huilong Li, et al. · Cancer Insight · 14
PDF
Correlation between the immune microenvironment and bladder cancer based on a prognostic miRNA risk model
2024 · Kun Mei, Zilu Chen, et al. · Cancer Insight · 12
PDF
Research Progress on the Relationship Between Mitochondrial Deoxyguanosine Kinase and Apoptosis and Autophagy in Lung Adenocarcinoma Cells
2022 · Chao Liu, Qin Qin, et al. · Cancer Insight · 10
PDF
A prognostic aging-related lncRNA risk model correlates with the immune microenvironment in HCC
2024 · Kun Mei, Zilu Chen, et al. · Cancer Insight · 8
PDF
Overcoming MTDH and MTDH-SND1 complex: driver and potential therapeutic target of cancer
2023 · Hao Shen, Jiayu Ding, et al. · Cancer Insight · 8
PDF
Enhanced understanding of the involvement of ferroptosis in tumorigenesis: A review of recent research advancements
2023 · Chunfeng Liu, Lei Ren · Cancer Insight · 8
PDF
Advances in the Use of Nanomaterials in Tumour Therapy: Challenges and Prospects
2023 · Hongmei Yang, Chen Li, et al. · Cancer Insight · 7
PDF
Role of macrophage polarization in cancer progression and their association with COVID-19 severity
2023 · Abhimanyu Thakur, Rumpa Banerjee, et al. · Cancer Insight · 6
PDF
Research progress of nanomedicine for tumor immunotherapy
2024 · Xingyi Wan, Mengyan Jiang, et al. · Cancer Insight · 5
PDF
Exploring Longitudinal MRI-Based Deep Learning Analysis in Parkinson’s Patients - A Short Survey Focus on Handedness
2024 · Yuan Gu, Ziyang Wang, et al. · Cancer Insight · 5
PDF
Advances in the Use of Nanomaterials in Tumour Therapy: Challenges and Prospects
2023 · Hongmei Yang, Chen Li, et al. · Cancer Insight · 5
PDF
E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis
2023 · Gui Zhang, Yunfang Zhang, et al. · Cancer Insight · 5
PDF
Drug Transport via Nanocarrier for Liver Cancer Treatment
2022 · Shafirah Hussein, Jaffr Rubenb · Cancer Insight · 5
PDF
The Dual Roles of S-Nitrosylation of Proteins in Cancer: Molecular Mechanisms and Recent Advancements
2024 · Yi Wu, Yanqi Li, et al. · Cancer Insight · 4
PDF
LTBP1 promotes the progression of triple negative breast cancer via activating the RhoA/ROCK signaling pathway
2023 · Jingcheng Zhang, Hong Deng, et al. · Cancer Insight · 4
PDF
Reassessing specificity/selectivity of taxane-based chemotherapy
2023 · Elizabeth R. Smith, Zheshen Li, et al. · Cancer Insight · 4
PDF
Cell membrane-coated nanoparticles for cancer therapy
2023 · Yasir Hameed, Mohsen Nabi-Afjadi, et al. · Cancer Insight · 4
PDF
Exploring the Multi-level Interaction Mechanism between Drugs and Targets Based on Artificial Intelligence
2022 · Yinfeng Yang, Jinghui Wang · Cancer Insight · 4
PDF
Comprehensive analyses reveal molecular and clinical characteristics of RNA modification writers across 32 cancer types
2024 · Jiayu Ding, Hao Shen, et al. · Cancer Insight · 3
PDF
Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity
2023 · Sindhu Ramesh, Peyton Johnson, et al. · Cancer Insight · 3
PDF
E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis
2023 · Gui Zhang, Yunfang Zhang, et al. · Cancer Insight · 3
PDF
Works count: 41
Citation count: 204
H-index: 8
I10-index: 7
2yr mean citedness: 4.222
Year
Topic
Type